[EN] RESORCINOL N-ARYL AMIDE COMPOUNDS, FOR USE AS PYRUVATE DEHYDROGENASE KINASE INHIBITORS [FR] COMPOSÉS DE RÉSORCINOL N-ARYLAMIDE DESTINÉS À ÊTRE UTILISÉS COMME INHIBITEURS DE PYRUVATE DÉSHYDROGÉNASE KINASE
[EN] RESORCINOL N-ARYL AMIDE COMPOUNDS, FOR USE AS PYRUVATE DEHYDROGENASE KINASE INHIBITORS [FR] COMPOSÉS DE RÉSORCINOL N-ARYLAMIDE DESTINÉS À ÊTRE UTILISÉS COMME INHIBITEURS DE PYRUVATE DÉSHYDROGÉNASE KINASE
[EN] RESORCINOL N-ARYL AMIDE COMPOUNDS, FOR USE AS PYRUVATE DEHYDROGENASE KINASE INHIBITORS<br/>[FR] COMPOSÉS DE RÉSORCINOL N-ARYLAMIDE DESTINÉS À ÊTRE UTILISÉS COMME INHIBITEURS DE PYRUVATE DÉSHYDROGÉNASE KINASE
申请人:VERNALIS R & D LTD
公开号:WO2015040425A1
公开(公告)日:2015-03-26
A compound of formula I: or a pharmaceutically acceptable salt thereof, wherein: Y is –CONR1- or optionally substituted arylene or optionally substituted heteroarylene; R1 is H, Cl, F, CH3 or CF3; 10 each R4 is independently H, CH3 or F; R5 is H or CH3; and each R2 and R6 is independently (Alk)n-Rn-(Alk)n-Rn-(Alk)n-X; The compounds of the invention are useful as resorcinol N-aryl amide (NAA) compounds, which are suitable for use as PDK inhibitors, for example for 15 inhibition of cancer cell proliferation.